Bristol Myers Squibb (BMYMP) Gains from Investment Securities (2016 - 2025)
Bristol Myers Squibb (BMYMP) has disclosed Gains from Investment Securities for 16 consecutive years, with -$308.0 million as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities changed N/A to -$308.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 million through Dec 2025, up 178.26% year-over-year, with the annual reading at -$232.0 million for FY2025, N/A changed from the prior year.
- Gains from Investment Securities for Q4 2025 was -$308.0 million at Bristol Myers Squibb, down from $336.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $336.0 million in Q2 2025, with the low at -$338.0 million in Q4 2021.
- Average Gains from Investment Securities over 5 years is -$73.0 million, with a median of -$33.5 million recorded in 2022.
- The sharpest move saw Gains from Investment Securities soared 690.91% in 2023, then plummeted 475.0% in 2024.
- Over 5 years, Gains from Investment Securities stood at -$338.0 million in 2021, then surged by 86.98% to -$44.0 million in 2022, then skyrocketed by 690.91% to $260.0 million in 2023, then plummeted by 108.85% to -$23.0 million in 2024, then crashed by 1239.13% to -$308.0 million in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$308.0 million, $336.0 million, and -$10.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.